FDA Clamping Down on Abuse of an OTC  Decongestant

THURSDAY, March 25, 2021 -- Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says.

Propylhexedrine is a nasal decongestant in over-the-counter...